|
ES2542989T3
(es)
|
2005-10-12 |
2015-08-13 |
Idera Pharmaceuticals, Inc. |
Compuestos oligonucleótidos inmuno reguladores (IRO) para modular la respuesta inmune basada en receptor semejante a Toll
|
|
JP2010522697A
(ja)
*
|
2007-03-16 |
2010-07-08 |
ユニバーシティ オブ フロリダ リサーチ ファウンデーション |
キナーゼタンパク質結合阻害剤
|
|
EP3087988A3
(en)
*
|
2008-10-06 |
2017-03-01 |
Idera Pharmaceuticals, Inc. |
Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
|
|
ES2616051T3
(es)
|
2008-12-02 |
2017-06-09 |
Wave Life Sciences Japan, Inc. |
Método para la síntesis de ácidos nucleicos modificados en el átomo de fósforo
|
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
|
JP2012516352A
(ja)
*
|
2009-01-30 |
2012-07-19 |
イデラ ファーマシューティカルズ インコーポレイテッド |
Ｔｌｒ９の合成アゴニスト
|
|
US8883174B2
(en)
|
2009-03-25 |
2014-11-11 |
The Board Of Regents, The University Of Texas System |
Compositions for stimulation of mammalian innate immune resistance to pathogens
|
|
CA2767253A1
(en)
|
2009-07-06 |
2011-01-13 |
Ontorii, Inc. |
Novel nucleic acid prodrugs and methods of use thereof
|
|
WO2011005942A2
(en)
*
|
2009-07-08 |
2011-01-13 |
Idera Pharmaceuticals, Inc. |
Oligonucleotide-based compounds as inhibitors of toll-like receptors
|
|
TR201809739T4
(tr)
*
|
2009-07-16 |
2018-07-23 |
Mallinckrodt Llc |
Toll benzeri reseptör 9 antagonistleri olarak (+)-morfinanlar ve bunların terapötik amaçlı kullanımları.
|
|
US10363251B2
(en)
|
2009-07-16 |
2019-07-30 |
Mallinckrodt Llc |
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
HRP20150566T1
(hr)
*
|
2009-08-27 |
2015-07-17 |
Idera Pharmaceuticals, Inc. |
Kompozicija za inhibiciju ekspresije gena i njegova upotreba
|
|
WO2011041311A2
(en)
*
|
2009-09-29 |
2011-04-07 |
Yale University |
Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods
|
|
JP2011084517A
(ja)
*
|
2009-10-15 |
2011-04-28 |
Koreaki Taniguchi |
核酸により活性化される自然免疫応答の抑制剤及びスクリーニング方法
|
|
WO2011117353A1
(en)
*
|
2010-03-24 |
2011-09-29 |
Mirrx Therapeutics A/S |
Bivalent antisense oligonucleotides
|
|
PL2593095T3
(pl)
|
2010-07-16 |
2019-12-31 |
Mallinckrodt Llc |
(+)-morfinany jako antagoniści receptora toll-podobnego 9 i ich terapeutyczne zastosowania
|
|
GB201014026D0
(en)
*
|
2010-08-20 |
2010-10-06 |
Ucl Business Plc |
Treatment
|
|
WO2012036215A1
(ja)
|
2010-09-17 |
2012-03-22 |
Taniguchi Tadatsugu |
Ｈｍｇｂタンパクによって仲介される免疫応答の活性化の抑制剤及びスクリーニング方法
|
|
EP2620428B1
(en)
|
2010-09-24 |
2019-05-22 |
Wave Life Sciences Ltd. |
Asymmetric auxiliary group
|
|
MX340363B
(es)
|
2010-11-19 |
2016-07-06 |
Idera Pharmaceuticals Inc |
Compuestos de oligonucleotidos inmuno-reguladores (iro) que modulan la respuesta inmune basada en receptores tipo toll.
|
|
GB201022049D0
(en)
*
|
2010-12-29 |
2011-02-02 |
Imp Innovations Ltd |
Methods
|
|
US8877722B2
(en)
|
2011-03-25 |
2014-11-04 |
Idera Pharmaceuticals, Inc. |
Compositions for inhibiting gene expression and uses thereof
|
|
US9050359B2
(en)
*
|
2011-05-16 |
2015-06-09 |
Haus Bioceuticals Inc. |
Compositions of herbal formulations and uses thereof
|
|
JP6128529B2
(ja)
|
2011-07-19 |
2017-05-17 |
ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． |
官能化核酸の合成のための方法
|
|
US9580708B2
(en)
*
|
2011-09-14 |
2017-02-28 |
Rana Therapeutics, Inc. |
Multimeric oligonucleotides compounds
|
|
US9982257B2
(en)
|
2012-07-13 |
2018-05-29 |
Wave Life Sciences Ltd. |
Chiral control
|
|
US9598458B2
(en)
|
2012-07-13 |
2017-03-21 |
Wave Life Sciences Japan, Inc. |
Asymmetric auxiliary group
|
|
MX356830B
(es)
*
|
2012-07-13 |
2018-06-15 |
Shin Nippon Biomedical Laboratories Ltd |
Adyuvante de acido nucleico quiral.
|
|
AU2013315225B2
(en)
|
2012-09-14 |
2018-11-08 |
Translate Bio Ma, Inc. |
Multimeric oligonucleotide compounds
|
|
CN103845731B
(zh)
*
|
2012-12-05 |
2015-12-02 |
复旦大学 |
抗st2/il-1r4抗体在制备防治瘙痒药物中的应用
|
|
CN103845730B
(zh)
*
|
2012-12-05 |
2015-12-09 |
复旦大学 |
抗st2/il-1 r4抗体在制备镇痛药物中的用途
|
|
CA2896537C
(en)
*
|
2013-01-08 |
2021-10-12 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
|
EP2762153A3
(en)
*
|
2013-02-05 |
2015-04-01 |
Nitto Denko Corporation |
Vaccine composition for mucosal administration
|
|
GB2514591A
(en)
*
|
2013-05-30 |
2014-12-03 |
Mologen Ag |
Predictive biomarker for cancer therapy
|
|
EP3095459A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having antitumor effect and antitumor agent
|
|
WO2015108046A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
|
|
US10144933B2
(en)
|
2014-01-15 |
2018-12-04 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
|
DK3094728T3
(da)
|
2014-01-16 |
2022-05-16 |
Wave Life Sciences Ltd |
Kiralt design
|
|
AU2015269412B2
(en)
|
2014-06-04 |
2020-03-12 |
Exicure Operating Company |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
|
US10286065B2
(en)
|
2014-09-19 |
2019-05-14 |
Board Of Regents, The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
JP2017537619A
(ja)
|
2014-11-21 |
2017-12-21 |
ノースウェスタン ユニバーシティ |
球状核酸ナノ粒子複合体の配列特異的細胞内取込
|
|
SK500652015A3
(sk)
|
2015-10-15 |
2017-05-03 |
Ústav Polymérov Sav |
Spôsob úpravy funkčného stavu ľubovoľnej mRNA umožňujúci jej selektívne a špecifické rozpoznanie
|
|
CN105597079A
(zh)
*
|
2016-01-11 |
2016-05-25 |
中国人民解放军第三军医大学第一附属医院 |
用于治疗银屑病的药物
|
|
CN105541947A
(zh)
*
|
2016-01-11 |
2016-05-04 |
中国人民解放军第三军医大学第一附属医院 |
拮抗tlr7/8及tlr9活化的药物分子及用途
|
|
US11339396B2
(en)
|
2016-06-08 |
2022-05-24 |
President And Fellows Of Harvard College |
Engineered viral vector reduces induction of inflammatory and immune responses
|
|
WO2018039629A2
(en)
|
2016-08-25 |
2018-03-01 |
Northwestern University |
Micellar spherical nucleic acids from thermoresponsive, traceless templates
|
|
EP3538513A1
(en)
|
2016-11-11 |
2019-09-18 |
Dynavax Technologies Corporation |
Toll-like receptor antagonist compounds and methods of use
|
|
BR112019010506A2
(pt)
|
2016-11-23 |
2019-09-17 |
Berlin Cures GmbH |
aptâmero para uso em terapia de um indivíduo por inibição e/ou supressão da ativação de tlr9
|
|
WO2018209270A1
(en)
|
2017-05-11 |
2018-11-15 |
Northwestern University |
Adoptive cell therapy using spherical nucleic acids (snas)
|
|
WO2019020732A1
(en)
|
2017-07-27 |
2019-01-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
METHODS FOR DETERMINING WHETHER A PATIENT SUFFERING FROM RHABDOMYOLYSIS REACHES A RESPONSE WITH AN ANTAGONIST TLR9
|
|
KR20200085812A
(ko)
|
2017-11-08 |
2020-07-15 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
바이러스 벡터-유도된 염증 반응을 억제하기 위한 조성물 및 방법
|
|
JP7423085B2
(ja)
*
|
2018-05-25 |
2024-01-29 |
プリミューン・セラピューティクス・インコーポレイテッド |
Ｔｌｒ７アゴニスト
|
|
MX2022006307A
(es)
|
2019-11-26 |
2022-08-22 |
Primmune Therapeutics Inc |
Agonistas del receptor tipo toll 7 (tlr7).
|
|
US20230323368A1
(en)
*
|
2020-01-10 |
2023-10-12 |
Sbi Biotech Co., Ltd. |
Novel tlr9 agonists
|